Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.

Companies have invested billions in generative AI (gen AI) and large language models (LLMs). Some now have chief AI officers. But despite the money and buzz, driving business impact cleary remains ...

In finance, the industry’s cornerstone companies don’t make a habit of dashing headlong to adopt bleeding-edge technologies. As in many conservative and regulated industries, leaders almost ...